Surgical treatment of postoperative, incidentally diagnosed small sporadic C-cell carcinomas of the thyroid

Langenbeck's Archives of Surgery

Volumn 385, Issue 8, 2000, Pages 526-530

  Cupisti, Kenko ^a   Simon, Dietmar ^a   Wolf, Achim ^a   Gerharz, Claus Dieter ^a   Goretzki, Peter E ^a   Dotzenrath, Cornelia ^a   Witte, Jürgen ^a   Röher, Hans Dietrich ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

C cell carcinoma; Calcitonin; Completion thyroidectomy; Follow up

Indexed keywords

ADULT; AGED; ARTICLE; CALCITONIN BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL FEATURE; FEMALE; HUMAN; MALE; POSTOPERATIVE CARE; PRIORITY JOURNAL; SURGICAL TECHNIQUE; THYROID CARCINOMA; THYROID MEDULLARY CARCINOMA; THYROIDECTOMY;

ADULT; AGED; CALCITONIN; CARCINOEMBRYONIC ANTIGEN; CARCINOMA, MEDULLARY; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PENTAGASTRIN; PROGNOSIS; RETROSPECTIVE STUDIES; THYROID DISEASES; THYROID NEOPLASMS; TREATMENT OUTCOME;

EID: 0034524971     PISSN: 14352443     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004230000166     Document Type: Article

References (25)

1. Kaserer K, Scheuba C, Neuhold N, Weinhäusel A, Vierhapper H, Haas O A, Niederle B (1998) C-cell hyperplasia and medullary thyroid carcinoma in patients routinely screened for serum calcitonin. Am J Surg Pathol 22:722-728
2. Heshmati HM, Gharib H, van Heerder JA, Sizemore GW (1997) Advances and controversies in the diagnosis and management of medullary thyroid carcinoma. Am J Med 103:60-69
3. Raue R, Kotzerke J, Reinwein D. Schröder S, Roher HD, Deckart H, Höfer R, Ritter M, Seif F, Buhr H, Beyer J, Schober O, Becker W, Neumann H, Calvi J, Winter J, Vogt H (1993) Prognostic factors in medullary thyroid carcinoma: evaluation of 741 patients from the German medullary thyroid carcinoma register. Clin Invest 71:7-12
4. Wells SA, Baylin SB, Gann DS, Parrel RE, Dilley WG, Preissig SH, Linehan WM, Cooper CW (1978) Medullary thyroid carcinoma: relationship of method of diagnosis to pathologic stag ing. Ann Surg 188:377-383
5. Pacini F, Fontanelli M, Fugazzola L, Elisei R, Romei C, Di Coscio G, Miccoli P, Pinchera A (1994) Routine measurement of serum calcitonin in nodular thyroid diseases allows the preoperative diagnosis of unsuspected sporadic medullary thyroid carcinoma. JCEM 78:826-829
6. Niccoli P, Wion-Barbot N, Caron P, Henry JF, de Micco C, Saint Andre JP, Bigorne JC, Modigliani E, ConteDevolx B (1997) Interest of routine measurement of serum calcitonin: study in a large series of thyroidectomized patients. JCEM 82:338-341
7. Beressi N, Campos JM, Beressi JP, Franc B, Nicolli-Sire P, Conte-Devolx B, Murat A, Caron P, Baldet L, Kraimps JL, Cohen R, Bigorne JC, Chabre O, Lecomte P, Modigliani E (1998) Sporadic medullary microcarcinoma of the thyroid: a retrospective analysis of eighty cases. Thyroid 8:1039-1044
8. van Heerden J, Grant CS, Gharib H, Hay ID, Ilstrup DM (1990) Long-ten course of patients with persistent hypercalcitoninemia after apparent cura live primary surgery for medullary th roid carcinoma. Ann Surg 212: 395-401
9. Moley MD, Wells SA, Dilley WG, Tisell LE (1993) Reoperation for recurrent or persistent medullary thyroi cancer. Surgery 114:1090-1096
10. Berndt I, Reuter M, Salier B, FrankRaue K, Groth P, Gruendorf M, Rau F, Ritter MM, Höppner W (1998) A new hot spot for mutations in the ret protooncogene causing familial medu lary thyroid carcinoma and multiple endocrine neoplasia type 2A. JCEM 83:770-774
11. Tisell LE, Dilley WG, Wells SA (199 Progression of postoperative residual medullary thyroid carcinoma as moni tored by plasma calcitonin levels. Sur gery 119:34-39
12. Moley JF, Dilley WG, DeBenedetti MK (1997) Improved results of cervical reoperation for medullary thyroid carcinoma. Ann Surg 225:734743
13. Hoefnagel CA, Delprat CC, Zanin D, van der School JB (1988) New radionuclide tracers for the diagnosis and therapy of medullary thyroid carcinoma. Clin Nucl Med 13:159-165
14. Vini L, Al-Saadi A, Fullbrook A, Harmer C, McCready RV (1998) The role of radionuclide imaging (DMSA, 123I-MIBG, 11 lln-Octreotide) in medullary thyroid cancer. Nucl Med Commun 19:384
15. Abdelmoumene N, Schlumberger M, Gardet P, Roche A, Travagli JP, Francese C, Parmentier C (1994) Selective venous sampling catheterisatic for localisation of persisting medullar thyroid carcinoma. Br J Cancer 69:1141-1144
16. Moley JF, Debenedetti K, Dilley WG. Tisell LE, Wells SA (1998) Surgical management of patients with persister or recurrent medullary thyroid cancer. J Intern Med 243:521-526
17. Tisell LE, Hansson G, Jansson S, Salander H (1986) Reoperation in the treatment of asymptomatic metastasiz ing medullary thyroid carcinoma. Surgery 99:60-66
18. Ben Mrad MD, Gardet P, Roche A, Rougier P, Calmettes C, Motte P, Parmentier C (1989) Value of venous catheterization and calcitonin studies in the treatment and management of clinically inapparent medullary thyroid carcinoma. Cancer 63:133-138
19. Tung WS, Vesely TM, Moley JF (1995) Laparoscopic detection of hepatic métastases in patients with residual or recurrent medullary thyroid cancer. Surgery 118:1024-1030
20. Gimm O, Ukkat J, Dralle H (1998) Determinative factors of biochemical cure after primary and reoperative surgery for sporadic medullary thyoid carcinoma. World J Surg 22:562-568
21. Goretzki PE, Simon D, Frilling A, Witte J, Reiners C, Grussendorf M, Horster FA, Roher HD (1993) Surgical reintervention for differentiated thyroid cancer. Br J Surg 80:1009-1012
22. Pezullo L, Delrio P, Losito NS, Caraco C, Mozzillo N (1997) Post-operative complications after completion thyroidectomy for differentiated thyroid cancer. Eur J Surg Oncol 23:215218
23. Saad MF, Ordonez NG, Rashid RK, Guido JJ, Hill CS, Hickey RC, Samaan N A (1984) Medullary carcinoma of the thyroid. A study of the clinical features and prognostic factors in 161 patients. Medicine 63:319-342
24. Kallinowski F, Buhr HJ, Meybier H, Eberhard! M, Herfarth C ( 1993) Medullary carcinoma of the thyroid therapeutic strategy derived from fifteen years of experience. Surgery 114:491-496
25. Wagner HE, Ruchti C, Studer M, Haldemann AR, Kinser J, Bürgi U (1996) Langzeitverlauf des medullären Schilddrüsenkarzinomes. Swiss Surg 2:181-186